Search Results

• • 111 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Antineoplastics/heparin: thrombocytopenia leading to fatal intracranial haemorrhage

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011274 words Brief article, Case ... 1270LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Etidronic acid/risedronic acid: femoral fractures in elderly patients

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011396 words Case study 1120LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Nevirapine: Stevens-Johnson syndrome

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011334 words Brief article, Case ... 1180LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Ibuprofen: Fournier's gangrene in an infant

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011357 words Brief article, Case ... 1040LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Carbamazepine/chlorpromazine/risperidone: dystonia, hepatitis, difficulty swallowing and glossitis

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011195 words Brief article, Case ... 1080LCase report A 52-year-old woman who was admitted with a severe manic episode developed dystonia during treatment with risperidone, mild glossitis with difficulty swallowing under carbamazepine, and hepatitis...

• Sodium polystyrene sulfonate/sorbitol: colonic necrosis in an elderly patient

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011151 words Brief article, Case ... 1260LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Diclofenac potassium: kounis syndrome (first report) in an elderly patient

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011305 words Brief article, Case ... 1180LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Suxamethonium chloride: rhabdomyolysis and heart arrest

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011239 words Brief article, Case ... 1080LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Antineoplastics: shock and febrile neutropenia

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011226 words Brief article, Case ... 1120LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Peginterferon-[alpha]-2a: various toxicities; 16 case reports)

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011253 words Brief article, Case ... 1260LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Immunosuppressants: Kaposi's sarcoma in a child

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011421 words Report 1240LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Ferrous sulfate/levothyroxine sodium interaction: hypothyroidism in an elderly patient

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011235 words Brief article, Case ... 1410LDrug interaction Case report A 95-year-old woman developed hypothyroidism during concomitant treatment with levothyroxine sodium for hyperthyroidism and ferrous sulfate [Tardyferon] for iron deficiency routes not...

• Carbon dioxide. (First report of subarachnoid haemorrhage in a patient undergoing diagnostic challenge

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011297 words Brief article, Case ... 1350LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Dimetindene: contact dermatitis and systemic allergic dermatitis in a child

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011201 words Brief article, Case ... 1190LCase report A 12-year-old boy developed contact dermatitis during treatment with dimetindene gel [Fenigel] for insect bites. He then developed systemic allergic dermatitis during treatment with dimetindene oral drops...

• Diphencyprone: pruritus, hyperpigmentation and irritation

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011152 words Brief article, Case ... 1190LCase report A 32-year-old man was diagnosed with generalised molluscum contagiosum on his eyelids, trunk and genitals. Two weeks after sensitisation therapy with 2% diphencyprone, an eczematous lesion was noted on...

• Influenza A virus vaccine-H1N1: Guillain-Barre syndrome

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011314 words Brief article, Case ... 1260LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Pregabalin: oromandibular dystonia

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011238 words Brief article, Case ... 1080LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Lacosamide/sodium channel antagonists interaction: neurotoxicity

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011655 words Case study 1030LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Bromisoval/lorazepam overdose. (Heart arrest and death

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 201178 words Brief article An event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Cytarabine: auricular oedema and palmar dyshidrotic eczema

  From:Reactions Weekly (Issue 1342)

  Mar. 12, 2011311 words Brief article, Case ... 1280LCase report A 38-year-old woman developed auricular oedema and palmar dyshidrotic eczema during cytarabine therapy route and frequency not stated. The woman was diagnosed with acute myeloid leukaemia and started...